unknown
Stage
About
Faron Pharmaceuticals is a clinical-stage biopharmaceutical company developing immunotherapies for cancer, including their lead drug candidate bexmarilimab, which targets myeloid cells to improve cancer treatment efficacy.
Explore Faron's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.